- Home
- IBIO vs CNFR Comparison
IBIO vs CNFR Comparison
Compare IBIO & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- CNFR
- Stock Information
- Founded
- IBIO 2008
- CNFR 2009
- Country
- IBIO United States
- CNFR United States
- Employees
- IBIO N/A
- CNFR N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- CNFR Property-Casualty Insurers
- Sector
- IBIO Health Care
- CNFR Finance
- Exchange
- IBIO Nasdaq
- CNFR Nasdaq
- Market Cap
- IBIO 11.9M
- CNFR 9.9M
- IPO Year
- IBIO N/A
- CNFR 2015
- Fundamental
- Price
- IBIO $0.87
- CNFR $1.77
- Analyst Decision
- IBIO Strong Buy
- CNFR
- Analyst Count
- IBIO 2
- CNFR 0
- Target Price
- IBIO $5.50
- CNFR N/A
- AVG Volume (30 Days)
- IBIO 1.9M
- CNFR 2.6M
- Earning Date
- IBIO 11-11-2025
- CNFR 11-12-2025
- Dividend Yield
- IBIO N/A
- CNFR N/A
- EPS Growth
- IBIO N/A
- CNFR N/A
- EPS
- IBIO N/A
- CNFR 2.45
- Revenue
- IBIO $400,000.00
- CNFR $52,654,000.00
- Revenue This Year
- IBIO N/A
- CNFR $25.91
- Revenue Next Year
- IBIO N/A
- CNFR N/A
- P/E Ratio
- IBIO N/A
- CNFR $0.83
- Revenue Growth
- IBIO 77.78
- CNFR N/A
- 52 Week Low
- IBIO $0.56
- CNFR $0.42
- 52 Week High
- IBIO $6.89
- CNFR $2.21
- Technical
- Relative Strength Index (RSI)
- IBIO 55.70
- CNFR 72.22
- Support Level
- IBIO $0.83
- CNFR $0.86
- Resistance Level
- IBIO $0.97
- CNFR $2.21
- Average True Range (ATR)
- IBIO 0.06
- CNFR 0.23
- MACD
- IBIO -0.00
- CNFR 0.12
- Stochastic Oscillator
- IBIO 50.00
- CNFR 70.29
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.